“Our heat treatment methods offer major improvements in tensile mechanical properties and enhancement of a range of other material properties for HPDC components,” says metallurgist Dr Roger Lumley of the Light Metals Flagship.
“Components treated with the new process do not show surface blistering or dimensional changes, they retain an as-cast appearance.”
Surprisingly, fatigue resistance of aluminium HPDC components heat-treated with the new process can be as high as for some wrought aluminium products, tending towards limiting behaviour usually observed in steel.
The new procedures may also substantially raise energy absorption during fracture, which has significant implications for crash-sensitive structural components made by high pressure die-casting.
For example, one common secondary alloy almost doubles in energy absorption, when heat treated specifically for this purpose.
“We envisage that this will make it possible to use HPDC components more widely in load carrying structural and safety applications,” Dr Lumley says.
Additionally, treated parts exhibit thermal conductivity about 20 per cent above their as-cast status, meaning that for engine or transmission applications heat can be transferred or removed more efficiently and quickly.
Potentially, since heat extraction operates more effectively, heat-treated HPDC parts could operate with lower amounts of fluid in cooling and lubrications systems.
The heat treatment process can easily be implemented in existing manufacturing facilities using conventional heat treatment equipment such as continuous belt furnaces, fluidised beds or furnace systems designed specifically for rapid heat treatment.
“It’s an attractive option because the HPDC process is more cost-effective than other manufacturing methods in mass production, and the net increase in design strength post-treatment may allow castings to be made using up to 30 per cent less metal. As a result, there is significant potential for cost reduction per part,” Dr Lumley says.
The researchers have also recently discovered a range of HPDC aluminium alloy compositions that display extraordinarily rapid strengthening behaviour, which has major cost and energy usage implications in manufacturing.
These alloys can be heat treated to high strength levels during a total cycle time of only 30 minutes and develop properties superior to conventional aluminium casting alloys requiring heat treatment in thermal cycles of up to 24 hours.
The CSIRO-led Light Metals Flagship is now seeking partners for a published case study.
“Following our success with evaluations conducted on HPDC parts up to more than 30kg, we would like to hear from OEM or Tier 1 suppliers who would be interested in submitting a component for heat treatment, and jointly publishing the results as a case study,” Dr Lumley said.
Technical data sheets, providing test results after treatment with the new process for a range of aluminum alloys under various tempering conditions, are available at:
http://www.csiro.au/science/ps1f1.html
Source: CSIRO Australia
Related stories:
Towards lower fuel use -- technologies for lighter cars
With oil prices at an historic high and global concern about vehicle emissions, consumer demand - and the focus in car manufacturing - is shifting to lightweight, low-fuel consumption cars.
Smoking and solid fuel use in homes in China projected to cause millions of deaths
If current levels of smoking and biomass and coal fuel use in homes continues, between 2003 and 2033 there will be an estimated 65 million deaths from chronic obstructive pulmonary disease (COPD) and 18 million deaths from lung cancer in China, accounting for 19% and 5% of all deaths in that country during this period.
Researchers find household insecurity associated with food insecurity, poor health
Researchers from Boston Medical Center have recently found that as household energy insecurity increases, the odds of infants and toddlers experiencing food insecurity, negative health, hospitalizations and developmental risks also increases. A household experiences energy insecurity when it lacks consistent access to the amount or the kind of energy needed for a healthy and safe life. These findings appear in the Vol. 122, No. 4, October 2008, issue of the journal
Pediatrics.
Scientists pioneer new treatment for prostate cancer
Scientists at Sunnybrook Research Institute (SRI) are developing and commercializing a promising novel therapy for the treatment of prostate cancer that may offer patients a faster and more precise treatment than existing clinical alternatives, with fewer side effects.
Golden Nanorods for Medical Applications
(PhysOrg.com) -- Gold nanoparticles are under consideration for a number of biomedical applications, such as tumor treatment. A German-American research team at Carnegie Mellon University in Pittsburgh, Hunter College in New York, and the RWTH Aachen has now developed a new method for the production of nanoscopic gold rods. In contrast to previous methods, they have achieved this without the use of cytotoxic additives. As they report in the journal
Angewandte Chemie, the synthesis is not carried out in water, but in an ionic liquid, a “liquid salt”.
NC State first university in nation to offer canine bone marrow transplants
Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to offer canine bone marrow transplants in a clinical setting.
Army personnel show increased risk for migraine
Two new studies show that migraine headaches are very common among U.S. military personnel, yet the condition is frequently underdiagnosed. The studies, appearing in
Headache, the peer-reviewed journal of the American Headache Society, examine the incidence among soldiers within 10 days of returning from a 1-year combat tour in Iraq , as well as U.S. Army officer trainees.
Can tomatoes carry the cure for Alzheimer's?
The humble tomato could be a suitable carrier for an oral vaccine against Alzheimer's disease, according to HyunSoon Kim from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) in Korea and colleagues from Digital Biotech Inc. and the Department of Biological Science at Wonkwang University.
